PR-inside.com is a website for submission of public relations distribution, news, and press releases.
 
Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Get the latest news
with our RSS feed
rss feed

More information
2014-09-17 03:33
Ocular Hypertension Global Clinical Trials Review, H1, 2014 : New market analysis published
Ocular Hypertension Global Clinical Trials Review, H1, 2014 Summary The clinical trial report, "Ocular Hypertension Global Clinical Trials Review, H1, 2014" provides data on the Ocular Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinica .. [ More ]
2014-09-17 03:32
Lupus Nephritis Global Clinical Trials Review, H1, 2014 : New market analysis published
Lupus Nephritis Global Clinical Trials Review, H1, 2014 Summary The clinical trial report, "Lupus Nephritis Global Clinical Trials Review, H1, 2014" provides data on the Lupus Nephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on .. [ More ]
2014-09-17 03:31
Hypotension Global Clinical Trials Review, H1, 2014 : New market analysis published
Hypotension Global Clinical Trials Review, H1, 2014 Summary The clinical trial report, "Hypotension Global Clinical Trials Review, H1, 2014" provides data on the Hypotension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypotension. .. [ More ]
2014-09-17 03:30
Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014 : New market analysis published
Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014 Summary The clinical trial report, "Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014" provides data on the Hidradenitis Suppurativa clinical trial scenario. This report provides elemental information and data relating .. [ More ]
2014-09-17 03:29
Cardiac Arrest Global Clinical Trials Review, H1, 2014 : New market analysis published
Cardiac Arrest Global Clinical Trials Review, H1, 2014 Summary The clinical trial report, "Cardiac Arrest Global Clinical Trials Review, H1, 2014" provides data on the Cardiac Arrest clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Car .. [ More ]
2014-09-17 03:28
Japan microvascular complications of diabetes market growth fueled by uptake of atrasentan, Optina and ranirestat
The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7 major markets (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major globa .. [ More ]
2014-09-17 03:27
UK microvascular complications of diabetes market to report strong growth for Regeneron/Bayer's Eylea over the
The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7 major markets (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major globa .. [ More ]
2014-09-17 03:26
Spain microvascular complications of diabetes market to report a dip in sales within the diabetic
The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7 major markets (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major globa .. [ More ]
2014-09-17 03:25
Italy microvascular complications of diabetes market to report strong growth as Eylea, Iluvien and Ozurdex
The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7 major markets (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major globa .. [ More ]
2014-09-17 03:24
German microvascular complications of diabetes market to report strong growth for Regeneron/Bayer's Eylea over the
The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7 major markets (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major globa .. [ More ]
2014-09-17 03:23
France microvascular complications of diabetes market attained revenues of US$153Mn in 2012
The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7 major markets (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major globa .. [ More ]
2014-09-17 03:22
US microvascular complications of diabetes market led by Roche/Novartis' Lucentis with sales of US$497Mn
The entire market for microvascular complications of diabetes (MCD), diabetic nephropathy, retinopathy, and neuropathy, is facing an extremely high level of unmet need across the 7 major markets (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in .. [ More ]
2014-09-17 03:21
Diagnostic ultrasound imaging is the most widely used technique to achieve early detection and clinical
An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic ultrasound imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. As with other develope .. [ More ]
2014-09-17 03:20
United States bone graft market led by Medtronic in 2013
Although autograft is still perceived as the gold-standard material in bone grafting, the wide array of alternatives available in the market has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the .. [ More ]
2014-09-17 03:19
Global bone grafts and substitutes market forecast to attain revenues of US$2.7Bn by 2020
Bone grafts and substitutes market is moving towards a period of steady growth by 2020. The global bone grafts and substitutes (BGS) market value will increase steadily over the coming years, rising from almost $2.1 billion in 2013 to approximately $2.7 billion by 2020, at a Compound Annual Growth R .. [ More ]
2014-09-17 03:18
Global endometriosis therapeutics market forecast to report a slow revenue decline to US$1.7Bn by 2017
Elagolix launch is forecast to revive the declining endometriosis treatment market by 2017. The global endometriosis therapeutics market will experience a slow decline over the coming years, with revenue decreasing from $1.88 billion in 2012 to $1.66 billion by 2017, at a negative Compound Annual Gr .. [ More ]
2014-09-17 03:17
Global pharma firms acquire local Latin American firms to target new markets and to lengthen
The pharmaceutical market in Latin America (LATAM) represents one of the two key global regions experiencing a higher investment in recent years. The top 15 pharmaceutical and healthcare deals reflect this trend in the categories of mergers and acquisitions (M&As), licensing agreements, and collabor .. [ More ]
2014-09-17 03:16
Global wind turbine towers market forecast to be worth US$19.3Bn by 2020
Global Wind Turbine Towers Market to Keep Growing, Despite Poor Grid Infrastructure. With wind power technology gaining increased popularity and institutional support from around the world, the wind turbine towers market is expected to increase from $12.1 billion in 2013 to $19.3 billion by 2020, at .. [ More ]
2014-09-17 03:15
Firewalls identified as unlikely for virtualization networks
Network Functions Virtualization (NFV) and Software Defined Networking (SDN) were hot topics at Mobile World Congress in 2013. Consider that a mere dress rehearsal. While attendees at the 2014 event later this month might not see these emerging architectures overtly hyped in the conference program, .. [ More ]
2014-09-17 03:14
In less developed countries establishment of private diagnostic laboratories associated with response to the low
According to World Health Organization (WHO) "Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another." Developing countries continue to experience the greates .. [ More ]



 
Promoted Articles:

   
 
Surf tips:

AskTheWeb.tv Share your knowledge
NewsEnvoy.com : Latest News
www.helloarticle.com (Englisch)
www.helloarticle.com/de/ (Deutsch)
Live-PR.com
Reporter7.com
   


Terms & Conditions | Privacy | About us | Contact PR-inside.com